Cyr61 in Carbon Nanotubes Restores Bone Density
Summary
The Board of Regents of the University of Texas System has filed Application US20260108472A1 for methods and compositions using recombinant Cyr61 carried in carbon nanotubes to restore Cyr61 expression in bone, increase bone density, and treat bone disease. The application was published April 23, 2026 with inventors Xiao-Dong Chen, Milos Marinkovic, and Qiuxia Dai. No compliance obligations or enforcement actions are associated with this patent application publication.
“Disclosed are methods and compositions for restoring Cyr61 in bone tissue. In certain aspects, the compositions comprise a recombinant Cyr61 carried in carbon nanotubes. The compositions may be used for various methods including restoring Cyr61 expression in bone, increasing bone density, or treating a bone disease in a patient.”
About this source
GovPing monitors USPTO Patent Applications - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 219 changes logged to date.
What changed
The Board of Regents of the University of Texas System has published patent application US20260108472A1 covering recombinant Cyr61 compositions carried in carbon nanotubes for restoring bone density and treating age-related bone loss. The application claims methods for increasing Cyr61 expression in bone tissue and treating bone diseases using the disclosed compositions.
For pharmaceutical and biotechnology companies developing bone disease therapeutics, this published application serves as prior art notice. Competitors should monitor prosecution of this application to assess potential freedom-to-operate implications for their own bone disease programs. The application does not yet grant enforceable patent rights; examination and potential grant would follow.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
REJUVENATING THE AGED SKELETAL MICROENVIRONMENT TO REVERSE AGE-RELATED BONE LOSS
Application US20260108472A1 Kind: A1 Apr 23, 2026
Assignee
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Inventors
Xiao-Dong CHEN, Milos MARINKOVIC, Qiuxia DAI
Abstract
Disclosed are methods and compositions for restoring Cyr61 in bone tissue. In certain aspects, the compositions comprise a recombinant Cyr61 carried in carbon nanotubes. The compositions may be used for various methods including restoring Cyr61 expression in bone, increasing bone density, or treating a bone disease in a patient.
CPC Classifications
A61K 9/5115 A61K 38/1709 A61K 38/29 A61P 19/10
Filing Date
2025-09-26
Application No.
19341099
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.